相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study
Andres Ramos-Fresnedo et al.
JOURNAL OF NEURO-ONCOLOGY (2022)
Clinical and radiographic characteristics of diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma: a single institution review
Dayton Grogan et al.
JOURNAL OF NEURO-ONCOLOGY (2022)
Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011-2017): a multicenter retrospective study from CGGA
Kenan Zhang et al.
CANCER BIOLOGY & MEDICINE (2022)
Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours
Craig Horbinski et al.
NATURE REVIEWS NEUROLOGY (2022)
An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment
Elena Verdugo et al.
CANCER COMMUNICATIONS (2022)
Molecular pathology and clinical implications of diffuse glioma
Ruichao Chai et al.
CHINESE MEDICAL JOURNAL (2022)
Diffuse astrocytic glioma, IDH-Wildtype, with molecular features of glioblastoma, WHO grade IV: A single-institution case series and review
Dennis Lee et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
MRI Features May Predict Molecular Features of Glioblastoma in Isocitrate Dehydrogenase Wild-Type Lower-Grade Gliomas
C. J. Park et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2021)
Molecular Characterization of True Low-Grade IDH-Wild-type Astrocytomas
Timothy E. Richardson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2021)
Morphologic and Molecular Aspects of Glioblastomas
Osorio Lopes Abath Neto et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification
Giulia Berzero et al.
NEURO-ONCOLOGY (2021)
Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria
C. Mircea S. Tesileanu et al.
NEURO-ONCOLOGY (2020)
cIMPACT-NOW update 3: recommended diagnostic criteria for Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV
Daniel J. Brat et al.
ACTA NEUROPATHOLOGICA (2018)
Advances in the molecular genetics of gliomas - implications for classification and therapy
Guido Reifenberger et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Epidemiologic and Molecular Prognostic Review of Glioblastoma
Jigisha P. Thakkar et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Morphological Characteristics of Brain Tumors Causing Seizures
Jong Woo Lee et al.
ARCHIVES OF NEUROLOGY (2010)
Classification of Brain Tumor Type and Grade Using MRI Texture and Shape in a Machine Learning Scheme
Evangelia I. Zacharaki et al.
MAGNETIC RESONANCE IN MEDICINE (2009)
Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management
Melanie S. M. van Breemen et al.
LANCET NEUROLOGY (2007)
Seizure disorders in patients with brain tumors
A Liigant et al.
EUROPEAN NEUROLOGY (2001)